Application is call: Data and Safety Monitoring Board (DSMB) Training 2026
The Africa Centres for Disease Control
and Prevention (Africa CDC) is an
autonomous institution of the African
Union that supports the Member
States (MS) in planning, preparing
and responding to the health threats
and disease outbreaks on the
continent. Its work is guided by the
leadership principles of credibility,
ownership, delegated authority, the
timely dissemination of information,
transparency, accountability and
value addition.
Among the units at Africa CDC is
the Science and Innovation division
whose mandate includes ensuring
effective safety monitoring in clinical
trials to uphold ethical research
standards and protect participant
well-being. Adverse events can
arise during the administration of
investiga-tional products, requiring
rigorous oversight to assess risks
and ensure timely interventions. The
Data and Safety Monitoring Board
(DSMB) plays a vital role in reviewing
clinical trial data, safe-guarding
trial participants and maintaining
the integrity of study results.
To strengthen DSMB ex-pertise
across the continent, Africa CDC, in
collaboration with the Safety Platform
for Emergency Vaccines (SPEAC), is
offering a structured training course
in data safety monitoring.
✅Eligibility
The training is open to professionals working in:
• Vaccine safety surveillance organisations
• Clinical trial hubs
• National Regulatory Authorities (NRAs)/National
PV centres
• Ethics committees
• Applicants should have a background in clinical trials or vaccine pharmacovigilance.
✅Trainers and Facilitators
The course will be led by a team of experienced
trainers from the Safety Platform for Emergency
Vaccines (SPEAC), a CEPI-funded initiative to enhance safety for CEPI-funded trials across various platforms for multiple priority pathogens.
✅Certification Requirements:
To receive a Certificate of Completion in Safety Monitoring in Clinical Trials, participants must:
• Achieve a passing score of 70% in all quizzes.
• Actively participate in all live sessions (maximum of two absences permitted).
• Score 70% or higher on the final exam (two attempts allowed).
✅Registration and Participant
Selection
Course start date: February 12, 2026
Registration Deadline: January 31, 2026
Required Application Details: Full Name, Country of Residence, Current Position, vaccine, DSMB and clinical trial related experience, Curriculum
Vitae, Contact Information (Phone & Email).
Application Deadline :31 January 2026
METHOD OF APPLICATION
• All applications must be submitted
using the online application form.
Incomplete applications will not be
considered.
• All applicants must provide the
following required information:
• A support letter from the
current employer
• Letters of recommendation
from two reputable
professional referees.
• A personal statement
(maximum 500 words)
demonstrating the candidate’s
commitment to medicine
safety in Africa. This statement
should outline the applicant’s
technical qualifications,
professional experience and
achievements, and articulate
their vision for the future
impact of effective medicine
safety and regulation systems
across the continent.
✅Selection Process
A total of 40 participants will be
chosen for each course based on
their professional background,
relevant experience and geographical
representation to ensure a diverse
cohort,
.jpeg )
